Effects of sympathomimetic tocolytic agents on the fetus.
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000318:Adrenergic beta-Agonists / Q000378:metabolism / Q000494:pharmacology*; D001786:Blood Glucose; D050260:Carbohydrate Metabolism; D002319:Cardiovascular System / Q000187:drug effects; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004734:Energy Metabolism; D005223:Fats / Q000378:metabolism; D005260:Female; D005318:Fetal Heart / Q000187:drug effects; D005333:Fetus / Q000187:drug effects*; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D007022:Hypotension / Q000139:chemically induced; D007231:Infant, Newborn; D007328:Insulin / Q000097:blood; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000201:enzymology / Q000378:metabolism / Q000502:physiology; D011188:Potassium / Q000097:blood; D011247:Pregnancy; D012119:Respiration / Q000187:drug effects; D013997:Time Factors; D014590:Uterine Contraction / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D001786:Blood Glucose; D002395:Catecholamines; D005223:Fats; D007328:Insulin; D006003:Glycogen; D000242:Cyclic AMP; D002394:Catechol O-Methyltransferase; D011188:Potassium